跳至主要内容
临床试验/CTRI/2024/03/063477
CTRI/2024/03/063477招募中2 期

Comparative study of efficacy and safety profile of topical minoxidil 5% versus oral minoxidil 2.5 mg in patients with androgenetic alopecia in tertiary care teaching hospital,Haldwani,Uttarakhand.

Dr Sally Rajkumari1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年10月3日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
To compare the efficacy of topical minoxidil 5% versus oral minoxidil 2.5mg in patients with androgenetic alopecia.

研究概览

简要总结

There is scarcity of study regarding efficacy and safety profile of oral minoxidil in patients with androgenetic alopecia in Kumaon region. There are studies encouraging the use of oral minoxidil. Therefore, this study is conceptualized to compare the efficacy and safety profile of topical minoxidil 5% versus oral minoxidil 2.5mg in patients with Androgenetic Alopecia to be conducted in Department of Pharmacology, Government Medical College Haldwani & Department of Dermatology, Dr. Susheela Tiwari Government Hospital, Haldwani, Uttarakhand.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients Of either sex with androgenetic alopecia ( Males- Stage 1 To 4 Of Hamilton-Norwood Scale; Females- Stage 1 And 2 Of Ludwig Scale).
  • Age 18 years and above.
  • Patients In good general health with no evidence of systemic illness.
  • Patients who will give written informed consent.

排除标准

  • Pregnant And lactating women.
  • Children less than 18 years.
  • Patients with systemic disease( PCOD, cardiac patients, epileptic, cancer,etc.)
  • Patients with active scalp infection, seborrheic dermatitis.
  • Patients with alopecia other than androgenetic alopecia.
  • Drug allergy.

结局指标

主要结局

To compare the efficacy of topical minoxidil 5% versus oral minoxidil 2.5mg in patients with androgenetic alopecia.

时间窗: Patients will be followed up at 0(baseline), 2 months, 4 months and 6 months.

次要结局

  • To study the adverse effect of topical minoxidil & oral minoxidil.(Patients will be followed up at 0(baseline), 2 months, 4 months & 6 months.)

研究者

发起方
Dr Sally Rajkumari
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验